Notably, in HNSCC tumors p63 expression is positively correlated with the expression of CD44, HAS3, and ABCC1 while the p63‐HA pathway acts as a negative prognostic factor for the survival of HNSCC patients [50]. The gene discussed is HAS3; the disease is head and neck squamous cell carcinoma.